Qube Research & Technologies (QRT)
CTNM

Qube Research & Technologies (QRT)’s Contineum Therapeutics CTNM Stock Holding History

Qube Research & Technologies (QRT)’s Portfolio CTNM Stock Details CTNM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$3.04M Buy
232,534
+189,456
+440% +$2.54M ﹤0.01% 1927
2025
Q4 		$492K Buy
+43,078
New +$491K ﹤0.01% 2813
2025
Q3 		– Sell
-10,924
Closed -$43.4K – 4023
2025
Q2 		$43.4K Buy
+10,924
New +$47.5K ﹤0.01% 3177

Other funds holding CTNM

SCM
Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
JJ
Johnson & Johnson New Brunswick, New Jersey $652M AUM 198.07% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Qube Research & Technologies (QRT)'s CTNM Position: Q1 2026 in Review

Qube Research & Technologies (QRT) increased its Contineum Therapeutics (CTNM) stake by 440% in Q1 2026, buying an estimated $2.54M and bringing the position to 232,534 shares worth $3.04M. The position accounts for ﹤0.01% of the portfolio, ranked #1927.

Qube Research & Technologies (QRT) first reported a position in CTNM in Q2 2025 and has held it in 3 quarters since. 90 funds tracked by Wall St. Rank hold CTNM as of Q1 2026.

  • Qube Research & Technologies (QRT) held 232,534 shares of Contineum Therapeutics worth $3.04M as of Q1 2026.
  • Qube Research & Technologies (QRT) bought 189,456 Contineum Therapeutics shares in Q1 2026, an estimated $2.54M.
  • Contineum Therapeutics made up ﹤0.01% of Qube Research & Technologies (QRT)'s portfolio in Q1 2026, its #1927 holding.
  • Qube Research & Technologies (QRT) first reported a position in Contineum Therapeutics in Q2 2025 and has held it in 3 quarters since.
  • 90 funds tracked by Wall St. Rank held Contineum Therapeutics as of Q1 2026.

Based on Qube Research & Technologies (QRT)'s 13F filing for Q1 2026, filed 15 May 2026.